ProstaGene

ProstaGene ProstaGene is a biotechnology start up company that is developing technology based on patents of the Pestell.

ProstaGene is a biotechnology start up company that is developing technology based on patents of the Founder, Dr. Richard G. ProstaGene LLC integrates proprietary molecular diagnostics with novel therapeutic screening and commercial experience in order to develop novel treatments for cancer. The company has developed a diagnostic test that distinguishes benign from malignant prostate cancer with a

predictive value of >98% in two retrospective clinical studies. The company has developed a prognostic test that defines a group of patients with poor outcome based on a signature of gene expression in the patients prostate tumor. The company has developed a novel platform for preclinical testing of therapies for metastatic prostate cancer in immune competent mice. The company has identified a therapeutic for metastatic prostate cancer that has shown to be highly effective in preclinical testing.

News Coverage: The Australian - Early Trauma inspired a life's workhttp://prostagene.com/363-2/
07/18/2017

News Coverage: The Australian - Early Trauma inspired a life's work

http://prostagene.com/363-2/

Richard Pestell was six when he first faced the devastating consequences of cancer.  His best friend died from the disease and then he watched both his parents die from it, so it’s no surpris…

News Coverage: Aussies at SpaceX, Apple, Google, Prostagene and Emotiv lead the talent diaspora https://t.co/oQaHecsO89
02/23/2017

News Coverage: Aussies at SpaceX, Apple, Google, Prostagene and Emotiv lead the talent diaspora https://t.co/oQaHecsO89

Australia has a talented diaspora of one million Australians overseas. A country of 24 million cannot afford to lose touch with its citizens thriving in the talent hotspots of the world. They might…

Why the former director of Jefferson's Kimmel Cancer Center is heading to Bucks County https://t.co/Vop9WLh9NJ
01/18/2017

Why the former director of Jefferson's Kimmel Cancer Center is heading to Bucks County https://t.co/Vop9WLh9NJ

The former long-time director of Jefferson’s Sidney Kimmel Cancer Center is joining a Bucks County research institute, where he will establish and lead the Pennsylvania Cancer and Regenerative Medi…

World - renowned physician Dr. Richard G. Pestell joins the Baruch S. Blumberg Institute. https://t.co/DMZHRg0hHn
01/18/2017

World - renowned physician Dr. Richard G. Pestell joins the Baruch S. Blumberg Institute. https://t.co/DMZHRg0hHn

World-renowned cancer physician scientist Richard G. Pestell, M.D., Ph.D., has joined the Baruch S. Blumberg Institute to establish and serve as presi

ProstaGene was assigned new patents in prostate cancer. Issued Patent No. 2012225232, Title: "Prostate Cancer Cell Line...
09/25/2016

ProstaGene was assigned new patents in prostate cancer. Issued Patent No. 2012225232, Title: "Prostate Cancer Cell Lines, Gene Signatures And Uses Thereof". Ref. 140993.00105 AU. issued August 25, 2016

http://prostagene.com/prostagene-assigned-new-patent-in-prostate-cancer-diagnostics/

ProstaGene was assigned new patents in prostate cancer. Issued Patent No. 2012225232, Title:  “Prostate Cancer Cell Lines, Gene Signatures And Uses Thereof”. Ref. 140993.00105 AU. issue…

ProstaGene was assigned important patents for cancer treatment. US Patent issued September 27, 2016 as U.S. Patent No. 9...
09/25/2016

ProstaGene was assigned important patents for cancer treatment. US Patent issued September 27, 2016 as U.S. Patent No. 9,453,836. “Use of modulators of CCR5 in the treatment of cancer and cancer metastasis” US Provisional Patent Application Nos. 61/646,593 and 61/646,586 (Reference Nos. 010236-5002-PR & 010236-5002-PR1)

http://prostagene.com/prostagene-assigned-new-patents-in-cancer-treatment/

ProstaGene was assigned important patents for cancer treatment. US Patent issued September 27, 2016 as U.S. Patent No. 9,453,836. “Use of modulators of CCR5 in the treatment of cancer and cancer me…

Consultant History LaRochelle Advisors, LLC 2013-2014 Collaboration and Business Development Consultant for biotechnolo...
12/29/2015

Consultant History LaRochelle Advisors, LLC 2013-2014 Collaboration and Business Development Consultant for biotechnology and pharmaceutical companies in the US, EU and China. As of November 2014, five partnerships executed for clients. BRISTOL-MYERS SQUIBB, Princeton, NJ 1993-2013 Executive Director, Business Development Head of China Business Development

http://prostagene.com/karen-j-larochelle/

Consultant History LaRochelle Advisors, LLC 2013-2014  Collaboration and Business Development Consultant for biotechnology and pharmaceutical companies in the US, EU and China. As of November 2014,...

New Team Member: David T. Bonkhttp://prostagene.com/david-t-bonk/
08/04/2015

New Team Member: David T. Bonk

http://prostagene.com/david-t-bonk/

David brings 30 years of experience in the biopharmaceutical industry, and has served as: Chair of the PhRMA Law Section. The global head lawyer at Bristol-Myers Squibb in three different practice ...

Address

Wynnewood, PA
19096

Website

Alerts

Be the first to know and let us send you an email when ProstaGene posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to ProstaGene:

Shortcuts

Share

Category